Insilico Medicine
About Insilico Medicine
Insilico Medicine is a biotechnology company that leverages artificial intelligence and machine learning to accelerate drug discovery and development. The company focuses on using advanced algorithms to identify potential drug candidates and optimize the drug development process, significantly reducing the time and cost associated with bringing new therapies to market.
Business Information
Target Customers
Industry Categories
Business Model
Funding Timeline
Founders
No founder information available.
Investors
No investor information available.
Recent Mentions
Insilico Medicine today announced the recent completion of its Series E financing. With strong support from investors, the company raised approximately $123 million in this round, surpassing its original fundraising target. https://t.co/UuwxcFhjBm
BREAKOUT SECTOR: AI-Driven Drug Discovery INSILICO MEDICINE: $255M Series D • AI discovers longevity targets in 18 months vs 6 years traditional • 30+ compounds in development • First AI-discovered anti-aging drug entering Phase 2 DEEP LONGEVITY: $14M seed round • AI
Similar Startups
Illimis Therapeutics
89% matchIllimis Therapeutics is a biotechnology company focused on developing innovative therapies to addres...
Isomorphic Labs
89% matchIsomorphic Labs is a London-based company that leverages artificial intelligence for computational d...
inductive_bio
88% matchA platform that accelerates the discovery of life-changing therapeutics using state-of-the-art AI mo...
Metly
87% matchAccelerate pharma product launches with AI